Ferroptosis contributes to endometrial fibrosis in intrauterine adhesions

Intrauterine adhesions (IUA), characterized by endometrial fibrosis, is a challenging clinical issue in reproductive medicine. We previously demonstrated that epithelial-mesenchymal transition (EMT) and fibrosis of endometrial stromal cells (HESCs) played a vital role in the development of IUA, but the precise pathogenesis remains elucidated. Ferroptosis has now been recognized as a unique form of oxidative cell death, but whether it is involved in endometrial fibrosis remains unknown. In the present study, we performed an RNA-seq of the endometria from 4 severe IUA patients and 4 normal controls. Enrichment analysis and protein-protein interactions (PPIs) network analysis of differentially expressed genes (DEGs) were conducted. Immunohistochemistry was used to assess Ferroptosis levels and cellular localization. The potential role of Ferroptosis for IUA was investigated by in vitro and in vivo experiments. Here, we demonstrated that Ferroptosis load is increased in IUA endometria. In vitro experiments showed that erastin-induced Ferroptosis promoted EMT and fibrosis in endometrial epithelial cells (P < 0.05), but did not lead to pro-fibrotic differentiation in endometrial stromal cells (HESCs). Cell co-culture experiments showed that erastin-stimulated epithelial cell supernatants promoted fibrosis in HESCs (P < 0.05). In vivo experiments suggested that elevation of Ferroptosis level in mice by erastin led to mild endometrial EMT and fibrosis. Meanwhile, the Ferroptosis inhibitor Fer-1 significantly ameliorated endometrial fibrosis in a dual-injury IUA murine model. Overall, our findings revealed that Ferroptosis may serve as a potential therapeutic target for endometrial fibrosis in IUA.

Endometrial fibrosis; Epithelial-mesenchymal transition; Ferroptosis; IUA; RNA-seq.